Comparison of aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VPIII for detection of T. vaginalis in symptomatic women: Performance parameters and epidemiological implications

Journal of Clinical Microbiology

Volumn 49, Issue 3, 2011, Pages 866-869

  Andrea, Sarah B ^a   Chapin, Kimberle C ^a,b  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AFFIRM ASSAY; AGE DISTRIBUTION; AGED; APTIMA TRICHOMONAS VAGINALIS TRANSCRIPTION MEDIATED AMPLIFICATION ASSAY; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MOLECULAR DIAGNOSIS; MOLECULAR PROBE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; VAGINA SMEAR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PARASITOLOGY; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; YOUNG ADULT;

AMBYSTOMA TIGRINUM STEBBENSI VIRUS; TRICHOMONAS VAGINALIS;

EID: 79952338833     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02367-10     Document Type: Article

References (33)

1. American College of Obstetricians and Gynecologists (ACOG). 2006. Vaginitis. ACOG Practice Bull. 72:1195-1206.
2. Anderson, M. R., and A. Karasz. 2005. How do clinicians manage vaginal complaints? An Internet survey. MedGenMed 7:61.
3. Andrea, S. B., and K. C. Chapin. 2010. 110th Gen. Meet. Am. Soc. Microbiol, poster C-595.
4. Boyadzhyan, B., T. Yashina, J. H. Yatabe, M. Patnaik, and C. S. Hill. 2004. Comparison of the APTIMA CT and GC assays with the APTIMA Combo 2 assay, the Abbott LCx assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol. 42:3089-3093.
5. Brown, H. L., D. D. Fuller, L. T. Jasper, T. E. Davis, and J. D. Wright. 2004. Clinical evaluation of Affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis. Infect. Dis. Obstet. Gynecol. 12:17-21.
6. Caliendo, A. M., et al. 2005. Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs. Infect. Dis. Obstet. Gynecol. 13:145-150.
7. Centers for Disease Control and Prevention (CDC). 3 February 2010, posting date. Reportable STDs in young people 15-24 years of age, by state. CDC, Atlanta, GA. http://www.cdc.gov/std/stats/by-age/15-24-all-STDs/default.htm.
8. Chapin, L. C., S. B. Andrea, R. Dickenson, and E. Kojic. 2009. Detection of Trichomonas vaginalis (TBV) from urine samples in a varied patient population using APTIMA Trichomonas analyte specific reagents (ASRs), abstr. P1.67. Abstr. 18th Meet. Int. Soc. Sex. Transm. Dis. Res. International Society for Sexually Transmitted Disease Research, Amsterdam, Netherlands.
9. Chapin, K. C., S. B. Andrea, J. Florczyk, and E. Kojic. 2010. Comparison of transcription mediated amplification (TMA) and polymerase chain reaction (PCR) methods for detection of Trichomonas vaginalis from SUN study patients, abstr. P75. Abstr. 2010 Natl. STD Prev. Conf. Centers for Disease Control and Prevention, Atlanta, GA.
10. Cotch, M. F., et al. 1997. Trichomonas vaginalis associated with low birth weight and preterm delivery. Sex. Transm. Dis. 24:353-360.
11. Francis, S. C., et al. 2008. Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male patients at the San Francisco STD Clinic, 2005-2006. Sex. Transm. Dis. 35:797-800.
12. Freeman, A. H., et al. 2010. Prevalence and correlates of Trichomonas vaginalis among incarcerated persons assessed using a highly sensitive molecular assay. Sex. Transm. Dis. 37:165-168.
13. Hardick, A., J. Hardick, B. J. Wood, and C. Gaydos. 2006. Comparison between the Gen-Probe transcription-mediated amplification Trichomonas vaginalis research assay and real-time PCR for Trichomonas vaginalis detection using a Roche LightCycler instrument with female self-obtained vaginal swab samples and male urine samples. J. Clin. Microbiol. 44:4197-4199.
14. Heine, P., and J. McGregor. 1993. Trichomonas vaginalis: a reemerging pathogen. Clin. Obstet. Gynecol. 36:137-144.
15. Hobbs, M. M., et al. 2006. Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis. J. Clin. Microbiol. 44:3994-3999.
16. Hollman, D., S. Coupey, A. Fox, and B. Herold. 2010. Screening for Trichomonas vaginalis in high-risk adolescent females with a new transcription-mediated nucleic acid amplification test (NAAT): associations with ethnicity, symptoms, and prior and current STIs. J. Pediatr. Adolesc. Gynecol. 23:312-316.
17. Huppert, J., et al. 2005. Use of immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens. J. Clin. Microbiol. 43:684-687.
18. Huppert, J., et al. 2007. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin. Infect. Dis. 45:194-198.
19. Kissinger, P., et al. 2009. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex. Transm. Dis. 36:11-16.
20. Lawing, L. F., S. R. Hedges, and J. R. Schwebke. 2000. Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR. J. Clin. Microbiol. 38:3585-3588.
21. Levett, P. N., et al. 2008. Evaluation of three automated nucleic acid ampli- fication systems for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in first-void urine specimens. J. Clin. Microbiol. 46:2109-2111. (Pubitemid 351831856)
22. Mann, J. R., et al. 2009. Trichomoniasis in pregnancy and mental retardation in children. Ann. Epidemiol. 19:891-899.
23. Munson, E., et al. 2010. Trichomonas vaginalis transcription-mediated amplification-based analyte-specific reagent and alternative target testing of primary clinical vaginal saline suspensions. Diagn. Microbiol. Infect. Dis. 68:66-72.
24. Munson, E., et al. 2008. Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence. J. Clin. Microbiol. 46:3368-3374.
25. Nye, M. B., J. R. Schwebke, and B. A. Body. 2009. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am. J. Obstet. Gynecol. 200:188.e1-188.e7.
26. Patel, S. R., et al. 2000. Systematic review of diagnostic tests of vaginal trichomoniasis. Infect. Dis. Obstet. Gynecol. 8:248-257.
27. Pattullo, L., et al. 2009. Stepwise diagnosis of Trichomonas vaginalis infection in adolescent women. J. Clin. Microbiol. 47:59-63.
28. Piperaki, E.-T., et al. 2010. Prevalence of Trichomonas vaginalis infection in women attending a major gynecological hospital in Greece: a cross-sectional study. J. Clin. Pathol. 63:249-253.
29. Rhode Island Department of Health. 2006, posting date. STD epidemiology summary: Rhode Island, 2006. Rhode Island Department of Health, Providence, RI. http://www.health.ri.gov/disease/communicable/std/std2006.pdf.
30. Schwiertz, A., D. Taras, K. Rusch, and V. Rusch. 2006. Throwing the dice for the diagnosis of vaginal complaints? Ann. Clin. Microbiol. Antimicrob. 5:4.
31. Sitay, A., et al. 2003. Rapid detection of Trichomonas vaginalis from vaginal specimens by transcription-mediated amplification, abstr. C-120, p. 140. Abstr. 103rd Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
32. Soper, D. 2004. Trichomoniasis: under control or under controlled? Am. J. Obstet. Gynecol. 190:281-290.
33. Stark, J. R., et al. 2009. Prospective study of Trichomonas vaginalis infection and prostate cancer incidence and mortality: Physicians' Health Study. J. Natl. Cancer Inst. 101:1406-1411.